Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

Spread This News Despite high rates of untreated osteoporosis and previous fractures among menopausal women in Zimbabwe — ...

Some people infected with HIV are teeming with virus, but don’t get sick. Their resistive powers probably come from a mix of ...

Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for people like Anna Engomba, the arrival of new, life-saving medication cannot ...

The 1) Market is expected to reach a substantial USD 34.83 billion by 2033, according to a new report. This reflects a ...

A 33-year-old man presented to our dermatology clinic with a 1-month history of two painless ulcers on his right arm and ...

The Pakistan Stock Exchange (PSX) held a gong ceremony to celebrate the listing of BF Biosciences Limited (BFBIO). BFBIO is a ...

Introduction In vitro diagnostic medical devices (IVDs) are reagents, packages, instruments, apparatus, or systems used to diagnose vari ...

DelveInsight's Pediatric Drugs Market Insights report provides the current and forecast market analysis, individual leading ...

A HIV-positive care worker who was taken off the roster at a nursing home after disclosing her medical history to her employer has been awarded €22,500 for disability discrimination. The Workplace ...

The growing occurrence of pediatric conditions like HIV, cancer, diabetes, and others is boosting the need for treatments specifically designed for children, making pediatric drug development ...